Taxotere
Taxotere is a pharmaceutical drug with 58 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.4%.
Success Metrics
Based on 37 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
29
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.1%
37 of 48 finished
22.9%
11 ended early
1
trials recruiting
58
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer
A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer
A Study of QLM2011 in Subjects With Advanced Solid Tumors
Clinical Trials (58)
Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer
A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer
A Study of QLM2011 in Subjects With Advanced Solid Tumors
Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer
A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)
Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere
Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer
Multi-academic Center Study of Xofigo Patients
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy
A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)
Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)
Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer
Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 58